Marcus Horwitz

Photo of Marcus Horwitz
Title(s)Professor, Medicine
SchoolMedicine
ORCID ORCID Icon0000-0001-6525-7147 Additional info
vCardDownload vCard
    Other Positions
    Title(s)Professor, MIMG


    Collapse Biography 
    Collapse education and training
    Cornell University, Ithaca, New YorkA.B. Physics06/1968Physics
    Columbia University, New York, New YorkM.D.06/1972Medicine
    Albert Einstein College of Medicine, Bronx, New York06/1974Internship and Residency
    Centers for Disease Control, Atlanta, Georgia06/1976Epidemic Intelligence Service Officer
    Albert Einstein College of Medicine, Bronx, New York06/1977Fellowship Infectious Diseases
    The Rockefeller University, New York, New York06/1980Fellowship Cellular Physiology & Immunology
    Collapse awards and honors
    Cornell University1968Phi Beta Kappa
    Cornell University1968cum laude in Physics and Distinction in All Subjects
    UC Berkeley1968National Science Foundation Fellowship, Lawrence Radiation Laboratory
    U.S. Army1975Certificate of Appreciation for services in the medical support of Operation New Life
    U.S Department of Health, Education and Welfare1975Certificate of Appreciation, Interagency Task Force for Indochina Refugees
    Center for Disease Control1976Alexander D. Langmuir Award
    National Institutes of Health 1977National Research Service Award
    American Cancer Society 1980Junior Faculty Research Award
    Hartford Foundation 1981Fellowship Award
    American Cancer Society 1985Faculty Research Award
    American Society of Clinical Investigation1985Election to Member
    American Society for Microbiology1989Divisional Lecture, Division B (Microbial Pathogenesis) 89th General Meeting
    MarDx1991James C. Feeley Award for Legionella Research (1st Annual Award)
    Infectious Diseases Society of America1991Oswald Avery (formerly Squibb) Award for Outstanding Research in Infectious Diseases
    MarDx1993James C. Feeley Award for Legionella Research
    American Association for the Advancement of Science1999Election to Fellow
    American Society for Microbiology 2001Divisional Lecture, Division U (Mycobacteriology) 101st Annual Meeting
    Elmira College2014Presidential Lecture
    University of Arizona2017Farness Lecturer

    Collapse Research 
    Collapse research activities and funding
    Identification by High Throughput Screening of Inhibitors of the Mycobacterium tuberculosis ESX-1 and ESX-5 Type VII Secretion Systems ? critical virulence determinants and novel drug targets
    NIH R21AI185484Jul 17, 2025 - Jun 30, 2027
    Role: Principal Investigator
    Efficacy and Safety of AI-enabled PRS Regimen VI (Clofazimine, Bedaquiline and Pyrazinamide) as Ultra-Short Course Therapy of LTBI in Non-Human Primates in a setting mimicking HIV co-infection
    NIH R01AI183978Mar 1, 2024 - Jan 31, 2027
    Role: Principal Investigator
    PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
    NIH U01AI170426Jul 7, 2022 - Apr 30, 2026
    Role: Co-Investigator
    Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
    NIH R01AI148122Mar 15, 2021 - Feb 28, 2026
    Role: Principal Investigator
    Composition, Atomic Structure and Function of the Francisella Type 6 Secretion System, a Distinct Subtype Essential for Phagosomal Escape, Intracellular Replication, and Virulence
    NIH R01AI151055Sep 21, 2020 - Aug 31, 2025
    Role: Principal Investigator
    Ultra-Short Course Treatment of Drug-Sensitive and Drug-Resistant Tuberculosis via Inhalation and Nanotherapeutic Delivery of Novel Drug Regimen
    Department of Defense W81XWH2010282May 15, 2020 - May 14, 2024
    Role: Principal Investigator
    Development of a Safe and Potent Vaccine Against Melioidosis using the LVS dcapB Vector Platform
    NIH R01AI141390Jun 1, 2019 - May 31, 2025
    Role: Principal Investigator
    Composition, structure, and mutational analysis of the Francisella Type VI Secretion System
    NIH R56AI125497Apr 10, 2018 - Mar 31, 2020
    Role: Principal Investigator
    Optimization and Advanced Proof-of-Concept Studies of a Listeria-vectored Multi-Antigenic Vaccine against Tuberculosis
    NIH R01AI135631Dec 1, 2017 - Nov 30, 2023
    Role: Principal Investigator
    Identification by High Throughput Screening of Inhibitors of Assembly and Secretion of the Francisella Type VI Secretion System
    NIH R21AI123630Feb 1, 2016 - Jan 31, 2019
    Role: Principal Investigator
    Pre-Exposure Prophylaxis Against Francisella tularensis
    NIH R01AI101189Jun 1, 2013 - May 31, 2018
    Role: Principal Investigator
    Pre-Exposure Prophylaxis Against Francisella tularensis
    NIH R56AI101189Aug 1, 2012 - May 31, 2013
    Role: Principal Investigator
    Development of a tularemia vaccine that is safer and more potent than LVS
    NIH R56AI084908Jul 6, 2010 - Jun 30, 2012
    Role: Principal Investigator
    A TB Vaccine for AIDS Patients
    NIH R01AI068413Jan 15, 2006 - Dec 31, 2011
    Role: Principal Investigator
    Novel Antimicrobial Agents Against M. tuberculosis
    NIH R01AI055352Jul 15, 2004 - Oct 31, 2009
    Role: Principal Investigator
    Characterization of the Francisella tularensis phagosome
    NIH R21AI053403Sep 15, 2002 - Aug 31, 2005
    Role: Principal Investigator
    M TUBERCULOSIS GLUTAMINE SYNTHETASE EXPORT &INHIBITION
    NIH R01AI042925Apr 1, 1998 - Mar 31, 2004
    Role: Principal Investigator
    Characterization of the M. tuberculosis phagosome
    NIH R01HL077000Sep 30, 1993 - Aug 31, 2009
    Role: Principal Investigator
    M TUBERCULOSIS PHAGOSOME
    NIH R01AI035275Sep 30, 1993 - Jun 30, 2004
    Role: Principal Investigator
    PROTECTIVE IMMUNITY AGAINST TUBERCULOSIS
    NIH R01AI035189Sep 30, 1993 - Jun 30, 1999
    Role: Principal Investigator
    EXOCHELINS, TUBERCULOSIS, AND AIDS
    NIH R01AI033790Jan 1, 1993 - Dec 31, 1996
    Role: Principal Investigator
    Development and Testing of New Tuberculosis Vaccines
    NIH R01AI031338Apr 1, 1991 - Feb 28, 2012
    Role: Principal Investigator
    IRON AND MONOCYTE ACTIVATION AGAINST A LUNG PATHOGEN
    NIH R01AI028825Feb 1, 1990 - Jan 31, 1996
    Role: Principal Investigator
    BIOLOGY OF MYCOBACTERIUM LEPRAE MONOCYTE INTERACTION
    NIH R01AI025143Jul 1, 1988 - Jun 30, 1992
    Role: Principal Investigator
    BIOLOGY OF MYCOBACTERIUM LEPRAE MONOCYTE INTERACTION
    NIH R22AI025143Jul 1, 1988 - Jun 30, 1991
    Role: Principal Investigator
    COMPLEMENT AND OPPORTUNISTIC MYCOBACTERIA IN AIDS
    NIH R01AI025681Sep 30, 1987 - Nov 30, 1991
    Role: Principal Investigator
    IMMUNE RESPONSE TO AN INTRACELLULAR PULMONARY PATHOGEN
    NIH R01AI022421Sep 1, 1985 - Jun 30, 1995
    Role: Principal Investigator
    TRANSMISSION ELECTRON MICROSCOPE AND MICROTOME
    NIH S10RR002334Jan 1, 1985 - Dec 31, 1985
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Epstein-Barr virus and multiple sclerosis: Mechanisms, therapeutic implications, and emerging interventions. J Neuroimmunol. 2026 Jul 30; 420:579043. Fazazi MR, Champagne-Jorgensen K, Islam T, Tweed K, Horwitz MS. PMID: 42541988.
      View in: PubMed   Mentions:    Fields:    
    2. Structure and potential role of T6SS effector PdpC in Francisella tularensis intracellular lifestyle. Commun Biol. 2026 Jun 25. Liu X, Clemens DL, Lee BY, Xia X, Fan H, Feng KY, Horwitz MA, Zhou ZH. PMID: 42350775.
      View in: PubMed   Mentions:
    3. Discovery and cryoEM structure of FPM13, a periplasmic metalloprotein unique to Francisella. PLoS Pathog. 2026 Mar; 22(3):e1014024. Clemens DL, Lee BY, Liu X, Zhou ZH, Horwitz MA. PMID: 41894480; PMCID: PMC13028475.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    4. Structure, identification, and characterization of the RibD-enolase complex in Francisella. Protein Cell. 2025 Dec 01; 16(12):1048-1053. Liu X, Clemens DL, Lee BY, Aguirre R, Horwitz MA, Zhou ZH. PMID: 40470850; PMCID: PMC12742849.
      View in: PubMed   Mentions:    Fields:    
    5. Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice. J Infect Dis. 2025 Sep 15; 232(3):e442-e447. Lee BY, Clemens DL, Masleša-Galic S, Nava S, Lo CY, Zink JI, Horwitz MA. PMID: 40498595; PMCID: PMC12455299.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    6. Universal Bacterium-Vectored COVID-19 Vaccine Expressing Early SARS-CoV-2 Conserved Proteins Cross-Protects Against Late Variants in Hamsters. Vaccines (Basel). 2025 Jun 12; 13(6). Jia Q, Bielefeldt-Ohmann H, Masleša-Galic S, Bowen RA, Horwitz MA. PMID: 40573964; PMCID: PMC12197694.
      View in: PubMed   Mentions:
    7. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. Hum Vaccin Immunother. 2025 Dec; 21(1):2507475. Jia Q, Bowen RA, Masleša-Galic S, Horwitz MA. PMID: 40417828; PMCID: PMC12118393.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    8. Discovery and CryoEM Structure of FPM13, a Periplasmic Metalloprotein Unique to Francisella. bioRxiv. 2025 May 08. Clemens DL, Lee BY, Liu X, Zhou ZH, Horwitz MA. PMID: 40654624; PMCID: PMC12247910.
      View in: PubMed   Mentions:
    9. Atomic Structure and Phospholipid Binding Properties of the Francisella Type VI Secretion System Effector Protein PdpC. bioRxiv. 2025 May 08. Liu X, Clemens DL, Lee BY, Xia X, Fan H, Feng KY, Horwitz MA, Zhou ZH. PMID: 40654996; PMCID: PMC12247734.
      View in: PubMed   Mentions:
    10. Structure, identification and characterization of the RibD-enolase complex in Francisella. bioRxiv. 2025 Mar 03. Liu X, Clemens DL, Lee BY, Aguirre R, Horwitz MA, Zhou ZH. PMID: 40093042; PMCID: PMC11908141.
      View in: PubMed   Mentions:
    11. LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice. mBio. 2024 04 10; 15(4):e0018624. Tullius MV, Bowen RA, Back PS, Masleša-Galic S, Nava S, Horwitz MA. PMID: 38511933; PMCID: PMC11005352.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    12. Editorial: Environmental factors in autoimmunity. Front Immunol. 2023; 14:1361884. Dunn SE, Correale J, Gommerman JL, Horwitz MS. PMID: 38292480; PMCID: PMC10824893.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial. Emerg Microbes Infect. 2023 Dec; 12(1):2187247. Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, Ding X, Hao X, Yang H, Sha W. PMID: 36872899; PMCID: PMC10026740.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. The rLVS ΔcapB/iglABC vaccine provides potent protection in Fischer rats against inhalational tularemia caused by various virulent Francisella tularensis strains. Hum Vaccin Immunother. 2023 12 15; 19(3):2277083. Mlynek KD, Cline CR, Biryukov SS, Toothman RG, Bachert BA, Klimko CP, Shoe JL, Hunter M, Hedrick ZM, Dankmeyer JL, Mou S, Fetterer DP, Qiu J, Lee ED, Cote CK, Jia Q, Horwitz MA, Bozue JA. PMID: 37975637; PMCID: PMC10760400.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    15. Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters. Microbiol Spectr. 2023 Apr 13; 11(2):e0503522. Jia Q, Bielefeldt-Ohmann H, Maison RM, Hartwig A, Masleša-Galic S, Bowen RA, Horwitz MA. PMID: 36916971; PMCID: PMC10100875.
      View in: PubMed   Mentions: 6     Fields:    
    16. Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge. Commun Biol. 2022 12 20; 5(1):1388. Jia Q, Masleša-Galic S, Nava S, Horwitz MA. PMID: 36539517; PMCID: PMC9764316.
      View in: PubMed   Mentions: 6  Translation:AnimalsCells
    17. Age-associated B cells are long-lasting effectors that impede latent γHV68 reactivation. Sci Rep. 2022 12 07; 12(1):21189. Mouat IC, Shanina I, Horwitz MS. PMID: 36477199; PMCID: PMC9729602.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    18. Gammaherpesvirus infection drives age-associated B cells toward pathogenicity in EAE and MS. Sci Adv. 2022 Nov 25; 8(47):eade6844. Mouat IC, Allanach JR, Fettig NM, Fan V, Girard AM, Shanina I, Osborne LC, Vorobeychik G, Horwitz MS. PMID: 36427301; PMCID: PMC9699667.
      View in: PubMed   Mentions: 17     Fields:    
    19. Inhibition of Th1 activation and differentiation by dietary guar gum ameliorates experimental autoimmune encephalomyelitis. Cell Rep. 2022 09 13; 40(11):111328. Fettig NM, Robinson HG, Allanach JR, Davis KM, Simister RL, Wang EJ, Sharon AJ, Ye J, Popple SJ, Seo JH, Gibson DL, Crowe SA, Horwitz MS, Osborne LC. PMID: 36103823.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    20. Atomic Structure of IglD Demonstrates Its Role as a Component of the Baseplate Complex of the Francisella Type VI Secretion System. mBio. 2022 10 26; 13(5):e0127722. Liu X, Clemens DL, Lee BY, Yang X, Zhou ZH, Horwitz MA. PMID: 36036641; PMCID: PMC9600919.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    21. Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice. mBio. 2022 06 28; 13(3):e0068722. Jia Q, Masleša-Galic S, Nava S, Horwitz MA. PMID: 35642945; PMCID: PMC9239278.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    22. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters. NPJ Vaccines. 2021 Mar 30; 6(1):47. Jia Q, Bielefeldt-Ohmann H, Maison RM, Masleša-Galic S, Cooper SK, Bowen RA, Horwitz MA. PMID: 33785745; PMCID: PMC8009914.
      View in: PubMed   Mentions: 48  
    23. Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection. Immunity. 2021 03 09; 54(3):526-541.e7. Xu W, Snell LM, Guo M, Boukhaled G, Macleod BL, Li M, Tullius MV, Guidos CJ, Tsao MS, Divangahi M, Horwitz MA, Liu J, Brooks DG. PMID: 33515487; PMCID: PMC7946746.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    24. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters. bioRxiv. 2020 Nov 18. Jia Q, Bielefeldt-Ohmann H, Maison R, Masleša-Galic S, Bowen R, Horwitz MA. PMID: 33236013; PMCID: PMC7685323.
      View in: PubMed   Mentions:
    25. Antiviral anticoagulation. Res Pract Thromb Haemost. 2020 Jul; 4(5):774-788. Pryzdial ELG, Sutherland MR, Lin BH, Horwitz M. PMID: 32685886; PMCID: PMC7354393.
      View in: PubMed   Mentions: 8  
    26. Atomic Structure of the Francisella T6SS Central Spike Reveals a Unique α-Helical Lid and a Putative Cargo. Structure. 2019 12 03; 27(12):1811-1819.e6. Yang X, Clemens DL, Lee BY, Cui Y, Zhou ZH, Horwitz MA. PMID: 31677891; PMCID: PMC6939872.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    27. AI-enabled parabolic response surface approach identifies ultra short-course near-universal TB drug regimens. Adv. Therap. 2019; 3:1900086. Horwitz, M.A., D.L. Clemens, and B-Y. Lee. View Publication.
    28. Backstories in Epidemiology: The babies are dying. 2019. Horwitz, M.A., C. Novick, and L.F. Novick. View Publication.
    29. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery. Acc Chem Res. 2019 06 18; 52(6):1531-1542. Chen W, Glackin CA, Horwitz MA, Zink JI. PMID: 31082188.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    30. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs. PLoS One. 2019; 14(5):e0215607. Clemens DL, Lee BY, Silva A, Dillon BJ, Masleša-Galic S, Nava S, Ding X, Ho CM, Horwitz MA. PMID: 31075149; PMCID: PMC6510528.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    31. PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA. Infect Immun. 2019 02; 87(2). Tullius MV, Nava S, Horwitz MA. PMID: 30455201; PMCID: PMC6346139.
      View in: PubMed   Mentions: 28     Fields:    Translation:Cells
    32. Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model. ACS Infect Dis. 2019 02 08; 5(2):281-291. Clemens DL, Lee BY, Plamthottam S, Tullius MV, Wang R, Yu CJ, Li Z, Dillon BJ, Zink JI, Horwitz MA. PMID: 30480992; PMCID: PMC13313570.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    33. Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility. PLoS One. 2018; 13(11):e0207469. Lee BY, Clemens DL, Silva A, Dillon BJ, Masleša-Galic S, Nava S, Ho CM, Horwitz MA. PMID: 30427938; PMCID: PMC6235396.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    34. Facile Strategy Enabling Both High Loading and High Release Amounts of the Water-Insoluble Drug Clofazimine Using Mesoporous Silica Nanoparticles. ACS Appl Mater Interfaces. 2018 Sep 26; 10(38):31870-31881. Chen W, Cheng CA, Lee BY, Clemens DL, Huang WY, Horwitz MA, Zink JI. PMID: 30160469.
      View in: PubMed   Mentions: 23     Fields:    
    35. Backstories in Epidemiology: The world’s deadliest poison. 2018. Marr, J.S. and M.A. Horwitz . . View Publication.
    36. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis. Front Cell Infect Microbiol. 2018; 8:154. Jia Q, Horwitz MA. PMID: 29868510; PMCID: PMC5963219.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    37. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Sci Rep. 2018 05 03; 8(1):7009. Jia Q, Bowen R, Dillon BJ, Masleša-Galic S, Chang BT, Kaidi AC, Horwitz MA. PMID: 29725025; PMCID: PMC5934503.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    38. The Francisella Type VI Secretion System. Front Cell Infect Microbiol. 2018; 8:121. Clemens DL, Lee BY, Horwitz MA. PMID: 29740542; PMCID: PMC5924787.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    39. Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active prfA* Regulon Boosts Mycobacterium bovis BCG Efficacy against Tuberculosis. Infect Immun. 2017 Sep; 85(9). Jia Q, Dillon BJ, Masleša-Galic S, Horwitz MA. PMID: 28630063; PMCID: PMC5563566.
      View in: PubMed   Mentions: 10     Fields:    
    40. A Pathogen-Specific Cargo Delivery Platform Based on Mesoporous Silica Nanoparticles. J Am Chem Soc. 2017 05 17; 139(19):6663-6668. Ruehle B, Clemens DL, Lee BY, Horwitz MA, Zink JI. PMID: 28437093.
      View in: PubMed   Mentions: 18     Fields:    
    41. Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. Blood. 2017 07 20; 130(3):245-257. Stefanova D, Raychev A, Arezes J, Ruchala P, Gabayan V, Skurnik M, Dillon BJ, Horwitz MA, Ganz T, Bulut Y, Nemeth E. PMID: 28465342; PMCID: PMC5520472.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    42. Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time. Nat Commun. 2017 01 24; 8:14183. Lee BY, Clemens DL, Silva A, Dillon BJ, Masleša-Galic S, Nava S, Ding X, Ho CM, Horwitz MA. PMID: 28117835; PMCID: PMC5287291.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    43. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge. Vaccine. 2016 09 22; 34(41):4969-4978. Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galic S, Horwitz MA. PMID: 27577555; PMCID: PMC5028307.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    44. Photothermal nanoblades for delivery of large-sized cargo into mammalian cells at high throughput. Proceedings of the 16th International Conference on Nanotechnology. Sendai, Japan, August 22-25, 2016. 2016; 47-50. Yi-Chien Wu Tuhin Santra Ting-Hsiang Wu Daniel L. Clemens Bai-Yu Lee Ximiao Wen Marcus A. Horwitz Michael A. Teitell Pei Yu Chou , Marcus A. Horwitz2 , Michael A. Teitell3 , Pei Yu Chiou1. View Publication.
    45. Redox-Triggered Release of Moxifloxacin from Mesoporous Silica Nanoparticles Functionalized with Disulfide Snap-Tops Enhances Efficacy Against Pneumonic Tularemia in Mice. Small. 2016 Jul; 12(27):3690-702. Lee BY, Li Z, Clemens DL, Dillon BJ, Hwang AA, Zink JI, Horwitz MA. PMID: 27246117.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    46. Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model. Proc Natl Acad Sci U S A. 2016 Apr 12; 113(15):E2172-9. Silva A, Lee BY, Clemens DL, Kee T, Ding X, Ho CM, Horwitz MA. PMID: 27035987; PMCID: PMC4839402.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    47. Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. PLoS Pathog. 2016 Jan; 12(1):e1005356. Cunningham CR, Champhekar A, Tullius MV, Dillon BJ, Zhen A, de la Fuente JR, Herskovitz J, Elsaesser H, Snell LM, Wilson EB, de la Torre JC, Kitchen SG, Horwitz MA, Bensinger SJ, Smale ST, Brooks DG. PMID: 26808628; PMCID: PMC4726812.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    48. Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy. PLoS One. 2015; 10(12):e0145179. Wang D, Shanina I, Toyofuku WM, Horwitz MS, Scott MD. PMID: 26674203; PMCID: PMC4692265.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    49. Mesoporous Silica Nanoparticles with pH-Sensitive Nanovalves for Delivery of Moxifloxacin Provide Improved Treatment of Lethal Pneumonic Tularemia. ACS Nano. 2015 Nov 24; 9(11):10778-89. Li Z, Clemens DL, Lee BY, Dillon BJ, Horwitz MA, Zink JI. PMID: 26435204.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    50. Tuberculosis: pH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice (Small 38/2015). Small. 2015 Oct; 11(38):5065. Hwang AA, Lee BY, Clemens DL, Dillon BJ, Zink JI, Horwitz MA. PMID: 26450161.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    51. Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis. Sci Rep. 2015 Sep 10; 5:13995. Casiraghi C, Márquez AC, Shanina I, Horwitz MS. PMID: 26356194; PMCID: PMC4564856.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    52. pH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice. Small. 2015 Oct; 11(38):5066-78. Hwang AA, Lee BY, Clemens DL, Dillon BJ, Zink JI, Horwitz MA. PMID: 26193431; PMCID: PMC5628743.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    53. Massively parallel delivery of large cargo into mammalian cells with light pulses. Nat Methods. 2015 May; 12(5):439-44. Wu YC, Wu TH, Clemens DL, Lee BY, Wen X, Horwitz MA, Teitell MA, Chiou PY. PMID: 25849636; PMCID: PMC5082232.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    54. Atomic structure of T6SS reveals interlaced array essential to function. Cell. 2015 Feb 26; 160(5):940-951. Clemens DL, Ge P, Lee BY, Horwitz MA, Zhou ZH. PMID: 25723168; PMCID: PMC4351867.
      View in: PubMed   Mentions: 102     Fields:    Translation:Cells
    55. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B. Infect Immun. 2014 Sep; 82(9):3900-9. Gillis TP, Tullius MV, Horwitz MA. PMID: 25001602; PMCID: PMC4187824.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCellsPHPublic Health
    56. The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses. Antioxid Redox Signal. 2014 Dec 01; 21(16):2246-61. Horwitz LD, Horwitz MA. PMID: 24684595; PMCID: PMC4224048.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    57. Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteins. J Biol Chem. 2014 Jun 27; 289(26):18279-89. Contreras H, Joens MS, McMath LM, Le VP, Tullius MV, Kimmey JM, Bionghi N, Horwitz MA, Fitzpatrick JA, Goulding CW. PMID: 24855650; PMCID: PMC4140288.
      View in: PubMed   Mentions: 49     Fields:    Translation:Cells
    58. Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci Res. 2013 Oct; 91(10):1292-302. Lacan G, Dang H, Middleton B, Horwitz MA, Tian J, Melega WP, Kaufman DL. PMID: 23907992; PMCID: PMC5800426.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    59. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge. Infect Immun. 2013 May; 81(5):1550-61. Jia Q, Bowen R, Sahakian J, Dillon BJ, Horwitz MA. PMID: 23439306; PMCID: PMC3647989.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCellsPHPublic Health
    60. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrob Agents Chemother. 2012 May; 56(5):2535-45. Clemens DL, Lee BY, Xue M, Thomas CR, Meng H, Ferris D, Nel AE, Zink JI, Horwitz MA. PMID: 22354311; PMCID: PMC3346638.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    61. O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages. Infect Immun. 2012 Mar; 80(3):952-67. Clemens DL, Lee BY, Horwitz MA. PMID: 22202123; PMCID: PMC3294633.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    62. Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity. 2011 May 27; 34(5):807-19. Egen JG, Rothfuchs AG, Feng CG, Horwitz MA, Sher A, Germain RN. PMID: 21596592; PMCID: PMC3164316.
      View in: PubMed   Mentions: 121     Fields:    Translation:AnimalsCells
    63. Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci U S A. 2011 Mar 22; 108(12):5051-6. Tullius MV, Harmston CA, Owens CP, Chim N, Morse RP, McMath LM, Iniguez A, Kimmey JM, Sawaya MR, Whitelegge JP, Horwitz MA, Goulding CW. PMID: 21383189; PMCID: PMC3064333.
      View in: PubMed   Mentions: 119     Fields:    Translation:Cells
    64. Replicating Vaccines: A New Generation (Dormitzer, P.R., C.W. Mandl, and R. Rappuoli, eds). New generation BCG vaccines. 2011; 119-169. Tullius, M.V., and M.A. Horwitz. . View Publication.
    65. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge. Infect Immun. 2010 Oct; 78(10):4341-55. Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA. PMID: 20643859; PMCID: PMC2950357.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    66. The Mycobacterium bovis bacille Calmette-Guerin phagosome proteome. Mol Cell Proteomics. 2010 Jan; 9(1):32-53. Lee BY, Jethwaney D, Schilling B, Clemens DL, Gibson BW, Horwitz MA. PMID: 19815536; PMCID: PMC2808266.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    67. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine. 2009 Jul 16; 27(33):4412-23. Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, Stagliano K, Haddock S, Mueller S, Fulkerson J, Scanga C, Grover A, Derrick SC, Morris S, Hone DM, Horwitz MA, Kaufmann SH, Sadoff JC. PMID: 19500523.
      View in: PubMed   Mentions: 70     Fields:    Translation:AnimalsCells
    68. Francisella tularensis phagosomal escape does not require acidification of the phagosome. Infect Immun. 2009 May; 77(5):1757-73. Clemens DL, Lee BY, Horwitz MA. PMID: 19237528; PMCID: PMC2681761.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    69. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One. 2009; 4(1):e4127. Richer MJ, Lavallée DJ, Shanina I, Horwitz MS. PMID: 19122812; PMCID: PMC2606033.
      View in: PubMed   Mentions: 76     Fields:    Translation:AnimalsCells
    70. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis. Vaccine. 2009 Feb 18; 27(8):1216-29. Jia Q, Lee BY, Clemens DL, Bowen RA, Horwitz MA. PMID: 19126421; PMCID: PMC2654553.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    71. New Generation Vaccines – 4th Edition. M. Levine, ed. Novel vaccines against tuberculosis. 2009; 516-531. Horwitz, M.A., P. Andersen, and S.H.E. Kaufmann.
    72. A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis. 2008 Nov 15; 198(10):1491-501. Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA. PMID: 18808333; PMCID: PMC2670060.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCellsCTClinical Trials
    73. Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis. Vaccine. 2009 Jan 14; 27(3):441-5. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. PMID: 19007841; PMCID: PMC2657049.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    74. A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. Infect Immun. 2008 Nov; 76(11):5200-14. Tullius MV, Harth G, Maslesa-Galic S, Dillon BJ, Horwitz MA. PMID: 18725418; PMCID: PMC2573348.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    75. The metabolic activity of Mycobacterium tuberculosis, assessed by use of a novel inducible GFP expression system, correlates with its capacity to inhibit phagosomal maturation and acidification in human macrophages. Mol Microbiol. 2008 May; 68(4):1047-60. Lee BY, Clemens DL, Horwitz MA. PMID: 18363792; PMCID: PMC3591484.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    76. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7199-204. Harth G, Zamecnik PC, Tabatadze D, Pierson K, Horwitz MA. PMID: 17438292; PMCID: PMC1855390.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    77. Uptake and intracellular fate of Francisella tularensis in human macrophages. Ann N Y Acad Sci. 2007 Jun; 1105:160-86. Clemens DL, Horwitz MA. PMID: 17435118.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    78. Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis. Clin Immunol. 2006 Dec; 121(3):339-49. Richer MJ, Fang D, Shanina I, Horwitz MS. PMID: 16963319.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    79. Desferri-Exochelin, a lipid-soluble, hexadentate iron chelator, effectively removes tissue iron. Transl Res. 2006 Aug; 148(2):63-71. Hodges YK, Weinberger HD, Stephens J, Horwitz MA, Horwitz LD. PMID: 16890146.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    80. Identification, recombinant expression, immunolocalization in macrophages, and T-cell responsiveness of the major extracellular proteins of Francisella tularensis. Infect Immun. 2006 Jul; 74(7):4002-13. Lee BY, Horwitz MA, Clemens DL. PMID: 16790773; PMCID: PMC1489726.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    81. All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis. Mol Microbiol. 2005 Nov; 58(4):1157-72. Harth G, Maslesa-Galic S, Tullius MV, Horwitz MA. PMID: 16262797.
      View in: PubMed   Mentions: 58     Fields:    Translation:Cells
    82. A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG. Vaccine. 2006 Mar 06; 24(10):1593-600. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. PMID: 16257099.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsPHPublic Health
    83. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun. 2005 Sep; 73(9):5892-902. Clemens DL, Lee BY, Horwitz MA. PMID: 16113308; PMCID: PMC1231130.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    84. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity. Vaccine. 2006 Jan 23; 24(4):443-51. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. PMID: 16125825.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    85. Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein. Infect Immun. 2005 Aug; 73(8):4676-83. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. PMID: 16040980; PMCID: PMC1201189.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    86. Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins. Microbes Infect. 2005 May; 7(5-6):947-54. Horwitz MA. PMID: 15919223.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    87. A two-plasmid system for stable, selective-pressure-independent expression of multiple extracellular proteins in mycobacteria. Microbiology (Reading). 2004 Jul; 150(Pt 7):2143-2151. Harth G, Masleša-Galic S, Horwitz MA. PMID: 15256557.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    88. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect Immun. 2004 Jun; 72(6):3204-17. Clemens DL, Lee BY, Horwitz MA. PMID: 15155622; PMCID: PMC415696.
      View in: PubMed   Mentions: 210     Fields:    Translation:HumansCells
    89. Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells. Virology. 2003 Sep 30; 314(2):510-20. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. PMID: 14554080.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    90. Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect Immun. 2003 Jul; 71(7):3927-36. Tullius MV, Harth G, Horwitz MA. PMID: 12819079; PMCID: PMC162033.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimalsCells
    91. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun. 2003 Apr; 71(4):1672-9. Horwitz MA, Harth G. PMID: 12654780; PMCID: PMC152073.
      View in: PubMed   Mentions: 73     Fields:    Translation:AnimalsCells
    92. Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo. Infect Immun. 2003 Jan; 71(1):456-64. Harth G, Horwitz MA. PMID: 12496196; PMCID: PMC143262.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    93. Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. Proc Natl Acad Sci U S A. 2002 Nov 26; 99(24):15614-9. Harth G, Horwitz MA, Tabatadze D, Zamecnik PC. PMID: 12427974; PMCID: PMC137765.
      View in: PubMed   Mentions: 21     Fields:    Translation:Cells
    94. The Mycobacterium tuberculosis phagosome in human macrophages is isolated from the host cell cytoplasm. Infect Immun. 2002 Oct; 70(10):5800-7. Clemens DL, Lee BY, Horwitz MA. PMID: 12228310; PMCID: PMC128330.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    95. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci U S A. 2002 Jun 25; 99(13):8915-20. Amersi F, Nelson SK, Shen XD, Kato H, Melinek J, Kupiec-Weglinski JW, Horwitz LD, Busuttil RW, Horwitz MA. PMID: 12084933; PMCID: PMC124398.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    96. Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization. J Immunol. 2002 Mar 01; 168(5):2560-7. Whitekus MJ, Li N, Zhang M, Wang M, Horwitz MA, Nelson SK, Horwitz LD, Brechun N, Diaz-Sanchez D, Nel AE. PMID: 11859152.
      View in: PubMed   Mentions: 54     Fields:    Translation:AnimalsCells
    97. An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation. 2001 Oct 30; 104(18):2222-7. Rosenthal EA, Bohlmeyer TJ, Monnet E, MacPhail C, Robertson AD, Horwitz MA, Burchenal JE, Horwitz LD. PMID: 11684635.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    98. High extracellular levels of Mycobacterium tuberculosis glutamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism. Infect Immun. 2001 Oct; 69(10):6348-63. Tullius MV, Harth G, Horwitz MA. PMID: 11553579; PMCID: PMC98770.
      View in: PubMed   Mentions: 46     Fields:    Translation:Cells
    99. Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells. Breast Cancer Res Treat. 2001 Sep; 69(1):69-79. Pahl PM, Horwitz MA, Horwitz KB, Horwitz LD. PMID: 11759830.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    100. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol. 2001 Mar 23; 307(2):671-81. Anderson DH, Harth G, Horwitz MA, Eisenberg D. PMID: 11254389.
      View in: PubMed   Mentions: 47     Fields:    Translation:Cells
    101. A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation. 2001 Jan 15; 71(1):112-8. Amersi F, Dulkanchainun T, Nelson SK, Farmer DG, Kato H, Zaky J, Melinek J, Shaw GD, Kupiec-Weglinski JW, Horwitz LD, Horwitz MA, Busuttil RW. PMID: 11211175.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    102. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A. 2000 Dec 05; 97(25):13853-8. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic' S. PMID: 11095745; PMCID: PMC17665.
      View in: PubMed   Mentions: 151     Fields:    Translation:AnimalsCells
    103. Mycobacterium tuberculosis and Legionella pneumophila phagosomes exhibit arrested maturation despite acquisition of Rab7. Infect Immun. 2000 Sep; 68(9):5154-66. Clemens DL, Lee BY, Horwitz MA. PMID: 10948139; PMCID: PMC101766.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    104. The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particles. J Immunol. 2000 Sep 01; 165(5):2703-11. Hiura TS, Li N, Kaplan R, Horwitz M, Seagrave JC, Nel AE. PMID: 10946301.
      View in: PubMed   Mentions: 52     Fields:    Translation:AnimalsCells
    105. An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro. J Biol Chem. 2000 Jun 09; 275(23):17821-6. Pahl PM, Yan XD, Hodges YK, Rosenthal EA, Horwitz MA, Horwitz LD. PMID: 10748174.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    106. Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect Immun. 2000 May; 68(5):2671-84. Clemens DL, Lee BY, Horwitz MA. PMID: 10768959; PMCID: PMC97474.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimalsCells
    107. Aberrantly low transferrin receptor expression on human monocytes is associated with nonpermissiveness for Legionella pneumophila growth. J Infect Dis. 2000 Apr; 181(4):1394-400. Byrd TF, Horwitz MA. PMID: 10762570.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    108. Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc Natl Acad Sci U S A. 2000 Jan 04; 97(1):418-23. Harth G, Zamecnik PC, Tang JY, Tabatadze D, Horwitz MA. PMID: 10618433; PMCID: PMC26678.
      View in: PubMed   Mentions: 48     Fields:    Translation:Cells
    109. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect Immun. 1999 Dec; 67(12):6510-7. Cohavy O, Harth G, Horwitz M, Eggena M, Landers C, Sutton C, Targan SR, Braun J. PMID: 10569769; PMCID: PMC97061.
      View in: PubMed   Mentions: 33     Fields:    Translation:Cells
    110. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med. 1999 May 03; 189(9):1425-36. Harth G, Horwitz MA. PMID: 10224282; PMCID: PMC2193054.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    111. T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. Infect Immun. 1999 May; 67(5):2665-70. Lee BY, Horwitz MA. PMID: 10225940; PMCID: PMC116023.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    112. Characterization of exochelins of the Mycobacterium bovis type strain and BCG substrains. Infect Immun. 1999 Apr; 67(4):2035-9. Gobin J, Wong DK, Gibson BW, Horwitz MA. PMID: 10085056; PMCID: PMC96566.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    113. Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria. J Biol Chem. 1999 Feb 12; 274(7):4281-92. Harth G, Horwitz MA. PMID: 9933629.
      View in: PubMed   Mentions: 29     Fields:    Translation:Cells
    114. Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined two-dimensional gel electrophoresis and mass spectrometry. Infect Immun. 1999 Jan; 67(1):327-36. Wong DK, Lee BY, Horwitz MA, Gibson BW. PMID: 9864233; PMCID: PMC96314.
      View in: PubMed   Mentions: 45     Fields:    Translation:Cells
    115. Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury. Proc Natl Acad Sci U S A. 1998 Apr 28; 95(9):5263-8. Horwitz LD, Sherman NA, Kong Y, Pike AW, Gobin J, Fennessey PV, Horwitz MA. PMID: 9560264; PMCID: PMC20249.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    116. Identification of iron-regulated proteins of Mycobacterium tuberculosis and cloning of tandem genes encoding a low iron-induced protein and a metal transporting ATPase with similarities to two-component metal transport systems. Microb Pathog. 1998 Mar; 24(3):133-43. Calder KM, Horwitz MA. PMID: 9514635.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    117. Expression and efficient export of enzymatically active Mycobacterium tuberculosis glutamine synthetase in Mycobacterium smegmatis and evidence that the information for export is contained within the protein. J Biol Chem. 1997 Sep 05; 272(36):22728-35. Harth G, Horwitz MA. PMID: 9278431.
      View in: PubMed   Mentions: 28     Fields:    Translation:Cells
    118. High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect Immun. 1997 Jun; 65(6):2321-8. Harth G, Lee BY, Horwitz MA. PMID: 9169770; PMCID: PMC175322.
      View in: PubMed   Mentions: 23     Fields:    Translation:Cells
    119. A new TB vaccine. The Immunologist. 1997; 5(1):15-20. Marcus A. Horwitz. .
    120. Characterization of exochelins of Mycobacterium avium: evidence for saturated and unsaturated and for acid and ester forms. J Bacteriol. 1996 Nov; 178(21):6394-8. Wong DK, Gobin J, Horwitz MA, Gibson BW. PMID: 8892850; PMCID: PMC178521.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    121. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med. 1996 Oct 01; 184(4):1349-55. Clemens DL, Horwitz MA. PMID: 8879207; PMCID: PMC2192850.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCells
    122. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun. 1996 Aug; 64(8):3038-47. Harth G, Lee BY, Wang J, Clemens DL, Horwitz MA. PMID: 8757831; PMCID: PMC174185.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    123. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med. 1996 Apr; 2(4):430-6. Walsh GP, Tan EV, dela Cruz EC, Abalos RM, Villahermosa LG, Young LJ, Cellona RV, Nazareno JB, Horwitz MA. PMID: 8597953.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansAnimalsCells
    124. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med. 1996 Apr 01; 183(4):1527-32. Gobin J, Horwitz MA. PMID: 8666910; PMCID: PMC2192514.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    125. Legionella pneumophila invasion of mononuclear phagocytes. Curr Top Microbiol Immunol. 1996; 209:99-112. Shuman HA, Horwitz MA. PMID: 8742248.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    126. Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol. 1995 Oct; 177(19):5644-52. Clemens DL, Lee BY, Horwitz MA. PMID: 7559354; PMCID: PMC177376.
      View in: PubMed   Mentions: 37     Fields:    Translation:Cells
    127. Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. J Clin Invest. 1995 Jul; 96(1):245-9. Lee BY, Horwitz MA. PMID: 7615794; PMCID: PMC185195.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    128. Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins. Proc Natl Acad Sci U S A. 1995 May 23; 92(11):5189-93. Gobin J, Moore CH, Reeve JR, Wong DK, Gibson BW, Horwitz MA. PMID: 7761471; PMCID: PMC41874.
      View in: PubMed   Mentions: 73     Fields:    Translation:Cells
    129. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1530-4. Horwitz MA, Lee BW, Dillon BJ, Harth G. PMID: 7878014; PMCID: PMC42553.
      View in: PubMed   Mentions: 158     Fields:    Translation:AnimalsCells
    130. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med. 1995 Jan 01; 181(1):257-70. Clemens DL, Horwitz MA. PMID: 7807006; PMCID: PMC2191842.
      View in: PubMed   Mentions: 241     Fields:    Translation:HumansCells
    131. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci U S A. 1994 Sep 27; 91(20):9342-6. Harth G, Clemens DL, Horwitz MA. PMID: 7937767; PMCID: PMC44808.
      View in: PubMed   Mentions: 65     Fields:    Translation:Cells
    132. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect Immun. 1994 Jan; 62(1):280-9. Schlesinger LS, Horwitz MA. PMID: 8262640; PMCID: PMC186098.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    133. The major iron-containing protein of Legionella pneumophila is an aconitase homologous with the human iron-responsive element-binding protein. J Bacteriol. 1993 Sep; 175(17):5666-76. Mengaud JM, Horwitz MA. PMID: 8366052; PMCID: PMC206625.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    134. Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomes. Infect Immun. 1993 Jul; 61(7):2803-12. Clemens DL, Horwitz MA. PMID: 8514382; PMCID: PMC280924.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    135. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J Clin Invest. 1993 Mar; 91(3):969-76. Byrd TF, Horwitz MA. PMID: 8450071; PMCID: PMC288049.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    136. Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease. J Clin Invest. 1993 Feb; 91(2):717-23. Blander SJ, Horwitz MA. PMID: 8432872; PMCID: PMC288014.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCellsPHPublic Health
    137. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun. 1992 Nov; 60(11):4781-92. Pal PG, Horwitz MA. PMID: 1398989; PMCID: PMC258232.
      View in: PubMed   Mentions: 79     Fields:    Translation:AnimalsCellsPHPublic Health
    138. Identification of a Legionella pneumophila locus required for intracellular multiplication in human macrophages. Proc Natl Acad Sci U S A. 1992 Oct 15; 89(20):9607-11. Marra A, Blander SJ, Horwitz MA, Shuman HA. PMID: 1409673; PMCID: PMC50181.
      View in: PubMed   Mentions: 150     Fields:    Translation:AnimalsCells
    139. Membrane sorting during phagocytosis: selective exclusion of major histocompatibility complex molecules but not complement receptor CR3 during conventional and coiling phagocytosis. J Exp Med. 1992 May 01; 175(5):1317-26. Clemens DL, Horwitz MA. PMID: 1569400; PMCID: PMC2119207.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    140. Interactions between macrophages and Legionella pneumophila. Curr Top Microbiol Immunol. 1992; 181:265-82. Horwitz MA. PMID: 1424783.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    141. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J Exp Med. 1991 Nov 01; 174(5):1031-8. Schlesinger LS, Horwitz MA. PMID: 1940785; PMCID: PMC2118995.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    142. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila. J Clin Invest. 1991 Oct; 88(4):1103-12. Byrd TF, Horwitz MA. PMID: 1918366; PMCID: PMC295561.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    143. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol. 1991 Sep 15; 147(6):1983-94. Schlesinger LS, Horwitz MA. PMID: 1679838.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    144. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest. 1991 Jul; 88(1):351-7. Byrd TF, Horwitz MA. PMID: 2056129; PMCID: PMC296041.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    145. Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella. J Immunol. 1991 Jul 01; 147(1):285-91. Blander SJ, Horwitz MA. PMID: 1711078.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    146. Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila. J Clin Invest. 1991 Mar; 87(3):1054-9. Blander SJ, Horwitz MA. PMID: 1999485; PMCID: PMC329900.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    147. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J Exp Med. 1990 Oct 01; 172(4):1201-10. Bellinger-Kawahara C, Horwitz MA. PMID: 2212949; PMCID: PMC2188623.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    148. An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease. J Clin Invest. 1990 Sep; 86(3):817-24. Blander SJ, Szeto L, Shuman HA, Horwitz MA. PMID: 2203824; PMCID: PMC296797.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    149. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol. 1990 Apr 01; 144(7):2771-80. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. PMID: 2108212.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansCells
    150. The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium. J Immunol. 1990 Apr 01; 144(7):2738-44. Marra A, Horwitz MA, Shuman HA. PMID: 2138651.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    151. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest. 1990 Apr; 85(4):1304-14. Schlesinger LS, Horwitz MA. PMID: 2138634; PMCID: PMC296567.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    152. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest. 1989 May; 83(5):1457-65. Byrd TF, Horwitz MA. PMID: 2496141; PMCID: PMC303847.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansCells
    153. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J Exp Med. 1989 Mar 01; 169(3):691-705. Blander SJ, Horwitz MA. PMID: 2926324; PMCID: PMC2189286.
      View in: PubMed   Mentions: 36     Fields:    Translation:CellsPHPublic Health
    154. A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge. J Clin Invest. 1989 Mar; 83(3):810-5. Blander SJ, Breiman RF, Horwitz MA. PMID: 2646318; PMCID: PMC303752.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCellsPHPublic Health
    155. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol. 1988 Jun 01; 140(11):3978-81. Nash TW, Libby DM, Horwitz MA. PMID: 3131422.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    156. Interferon-gamma and antibiotics fail to act synergistically to kill Legionella pneumophila in human monocytes. J Interferon Res. 1988 Jun; 8(3):283-93. Bhardwaj N, Horwitz MA. PMID: 3137275.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    157. Intracellular parasitism. Curr Opin Immunol. 1988; 1(1):41-6. Horwitz MA. PMID: 3077298.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    158. Characterization of avirulent mutant Legionella pneumophila that survive but do not multiply within human monocytes. J Exp Med. 1987 Nov 01; 166(5):1310-28. Horwitz MA. PMID: 3681188; PMCID: PMC2189638.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    159. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med. 1987 Nov 01; 166(5):1377-89. Payne NR, Horwitz MA. PMID: 3316470; PMCID: PMC2189647.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    160. Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens. J Exp Med. 1987 Mar 01; 165(3):799-811. Breiman RF, Horwitz MA. PMID: 3819647; PMCID: PMC2188290.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCellsPHPublic Health
    161. Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. J Immunol. 1986 Oct 15; 137(8):2662-9. Bhardwaj N, Nash TW, Horwitz MA. PMID: 3093580.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    162. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. J Immunol. 1986 Aug 01; 137(3):983-7. Kaplan G, Nathan CF, Gandhi R, Horwitz MA, Levis WR, Cohn ZA. PMID: 3088117.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    163. Phagosome-lysosome fusion. Biochem Soc Trans. 1986 Apr; 14(2):256-7. Gabay JE, Horwitz MA, Cohn ZA. PMID: 3709950.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    164. Purification of Legionella pneumophila major outer membrane protein and demonstration that it is a porin. J Bacteriol. 1985 Apr; 162(1):85-91. Gabay JE, Blake M, Niles WD, Horwitz MA. PMID: 2579942; PMCID: PMC218957.
      View in: PubMed   Mentions: 42     Fields:    Translation:Cells
    165. Isolation and characterization of the cytoplasmic and outer membranes of the Legionnaires' disease bacterium (Legionella pneumophila). J Exp Med. 1985 Feb 01; 161(2):409-22. Gabay JE, Horwitz MA. PMID: 3882879; PMCID: PMC2187562.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    166. Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J Cell Biol. 1984 Dec; 99(6):1936-43. Horwitz MA, Maxfield FR. PMID: 6501409; PMCID: PMC2113576.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansAnimalsCells
    167. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J Clin Invest. 1984 Sep; 74(3):771-82. Nash TW, Libby DM, Horwitz MA. PMID: 6470140; PMCID: PMC425231.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCells
    168. Defective production of monocyte-activating cytokines in lepromatous leprosy. J Exp Med. 1984 Mar 01; 159(3):666-78. Horwitz MA, Levis WR, Cohn ZA. PMID: 6366107; PMCID: PMC2187261.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    169. Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell. 1984 Jan; 36(1):27-33. Horwitz MA. PMID: 6692469.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCells
    170. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med. 1983 Dec 01; 158(6):2108-26. Horwitz MA. PMID: 6644240; PMCID: PMC2187157.
      View in: PubMed   Mentions: 334     Fields:    Translation:HumansCells
    171. Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes. J Exp Med. 1983 Oct 01; 158(4):1319-31. Horwitz MA. PMID: 6619736; PMCID: PMC2187375.
      View in: PubMed   Mentions: 318     Fields:    Translation:HumansCells
    172. Cell-mediated immunity in Legionnaires' disease. J Clin Invest. 1983 Jun; 71(6):1686-97. Horwitz MA. PMID: 6345589; PMCID: PMC370373.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    173. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin. J Clin Invest. 1983 Jan; 71(1):15-26. Horwitz MA, Silverstein SC. PMID: 6848556; PMCID: PMC436833.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCells
    174. Symbiotic interactions between Legionella pneumophila and human leukocytes. Int Rev Cytol Suppl. 1983; 14:307-28. Horwitz MA. PMID: 6341276.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    175. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med. 1982 Dec 23; 307(26):1593-7. Van Voorhis WC, Kaplan G, Sarno EN, Horwitz MA, Steinman RM, Levis WR, Nogueira N, Hair LS, Gattass CR, Arrick BA, Cohn ZA. PMID: 6216407.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    176. Phagocytosis of microorganisms. Rev Infect Dis. 1982; 4(1):104-23. Horwitz MA. PMID: 6122253.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    177. Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria. J Exp Med. 1981 Nov 01; 154(5):1618-35. Horwitz MA, Silverstein SC. PMID: 7299350; PMCID: PMC2186504.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    178. Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication. J Exp Med. 1981 Feb 01; 153(2):398-406. Horwitz MA, Silverstein SC. PMID: 7241049; PMCID: PMC2186075.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    179. Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med. 1981 Feb 01; 153(2):386-97. Horwitz MA, Silverstein SC. PMID: 7017062; PMCID: PMC2186085.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    180. The roles of the Fc and C3 receptors in the phagocytosis and killing of bacteria by human phagocytes. J Reticuloendothel Soc. 1980 Dec; 28(Suppl):17s-26s. Horwitz MA. PMID: 7003137.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    181. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest. 1980 Sep; 66(3):441-50. Horwitz MA, Silverstein SC. PMID: 7190579; PMCID: PMC371671.
      View in: PubMed   Mentions: 331     Fields:    Translation:HumansAnimalsCells
    182. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest. 1980 Jan; 65(1):82-94. Horwitz MA, Silverstein SC. PMID: 6985617; PMCID: PMC371342.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansAnimalsCells
    183. Outbreaks of waterborne disease in the United States, 1975. Journal of Infectious Diseases. 1978; 137(3):370-374. Robert E. Black Marcus A. Horwitz Gunther F. Craun. . View Publication.
    184. Outbreaks of food-borne disease in the United States, 1975. Journal of Infectious Diseases. 1978; 137(2):213-218. Robert E. Black Roscoe C. Cox Marcus A. Horwitz. . View Publication.
    185. A large outbreak of foodborne salmonellosis on the Navajo Nation Indian Reservation, epidemiology and secondary transmission. Am J Public Health. 1977 Nov; 67(11):1071-6. Horwitz MA, Pollard RA, Merson MH, Martin SM. PMID: 911019; PMCID: PMC1653773.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    186. Specific diagnosis of foodborne disease. Gastroenterology. 1977 Aug; 73(2):375-81. Horwitz MA. PMID: 873148.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    187. Food-borne botulism in the United States, 1970-1975. J Infect Dis. 1977 Jul; 136(1):153-9. Horwitz MA, Hughes JM, Merson MH, Gangarosa EJ. PMID: 886204.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    188. Foodborne disease outbreaks of chemical etiology in the United States, 1970-1974. Am J Epidemiol. 1977 Mar; 105(3):233-44. Hughes JM, Horwitz MA, Merson MH, Barker WH, Gangarosa EJ. PMID: 557897.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    189. Type A botulism from commercially canned beef stew. South Med J. 1977 Jan; 70(1):5-7. Blake PA, Horwitz MA, Hopkins L, Lombard GL, McCroan JE, Prucha JC, Merson MH. PMID: 320672.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    190. Foodborne disease outbreaks traced to poultry, United States, 1966 1974. Journal of Milk and Food Technology. 1976; 39(12):859-863. Marcus A. Horwitz Eugene J. Gangarosa. . View Publication.
    191. Nursery outbreak of peritonitis with pneumoperitoneum probably caused by thermometer-induced rectal perforation. Am J Epidemiol. 1976 Dec; 104(6):632-44. Horwitz MA, Bennett JV. PMID: 998611.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    192. Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient. A method for selectively removing interfering substances from clinical specimens. Am J Clin Pathol. 1976 Oct; 66(4):737-42. Horwitz MA, Hatheway CL, Dowell VR. PMID: 970375.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    193. From the center of disease control. Outbreaks of food-borne disease in the United States, 1974. J Infect Dis. 1976 Sep; 134(3):306-12. Horwitz MA, Hughes JM. PMID: 978000.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    194. Outbreaks of waterborne disease in the United States, 1974. J Infect Dis. 1976 May; 133(5):588-93. Horwitz MA, Hughes JM, Craun GF. PMID: 772133.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    195. A continuing common-source outbreak of botulism in a family. Lancet. 1975 Nov 01; 2(7940):861-3. Horwitz MA, Marr JS, Merson MH, Dowell VR, Ellis JM. PMID: 53340.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    196. Staphylococcal food poisoning aboard a commercial aircraft. Lancet. 1975 Sep 27; 2(7935):595-9. Eisenberg MS, Gaarslev K, Brown W, Horwitz M, Hill D. PMID: 51419.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Marcus's Networks
    Concepts (708)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California